Phio (PHIO) Director Patricia Bradford Buys 6,500 Shares

What Happened
Patricia A. Bradford, a director of Phio Pharmaceuticals Corp. (PHIO), made an open-market purchase of 6,500 shares on 2026-09-24 at $1.01 per share, for a total cash outlay of approximately $6,583. This was a purchase (transaction code P), which is often viewed as a more informative signal than routine sales because it reflects an insider adding to their stake.

Key Details

• Transaction date and price: 2026-09-24 — 6,500 shares at $1.01 per share.
• Total value: ~$6,583.
• Shares owned after transaction: Not specified in the provided excerpt; the filing notes holdings include shares underlying unvested restricted stock units (see footnote F1).
• Footnote: F1 indicates the reported holdings include common stock underlying unvested restricted stock units.
• Filing timeliness: Report filed 2026-09-25 (the day after the transaction); no late filing flag indicated.

Context
This was a straightforward open-market purchase (P). There were no option exercises, gifts, or tax-withholding events reported. The amount is small in dollar terms, so while purchases are generally notable, this one represents a modest increase in the director’s stake.